|
1.
|
Severino P, Alvares AM, Michaluart P Jr,
Okamoto OK, Nunes FD, Moreira-Filho CA and Tajara EH: Global gene
expression profiling of oral cavity cancers suggests molecular
heterogeneity within anatomic subsites. BMC Res Notes. 1:113–121.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Scully C, Field JK and Tanzawa H: Genetic
aberrations in oral or head and neck squamous cell carcinoma
(SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle
control. Oral Oncol. 36:256–263. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Scully C, Field JK and Tanzawa H: Genetic
aberrations in oral or head and neck squamous cell carcinoma 3:
clinicopathological applications. Oral Oncol. 36:404–413. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Sticht C, Freier K, Knöpfle K,
Flechtenmacher C, Pungs S, Hofele C, Hahn M, Joos S and Lichter P:
Activation of MAP kinase signaling through ERK5 but not ERK1
expression is associated with lymph node metastases in oral
squamous cell carcinoma (OSCC). Neoplasia. 10:462–470.
2008.PubMed/NCBI
|
|
5.
|
Macfarlane GJ, Zheng T, Marshall JR,
Boffetta P, Niu S, Brasure J, Merletti F and Boyle P: Alcohol,
tobacco, diet and the risk of oral cancer: a pooled analysis of
three case-control studies. Eur J Cancer B Oral Oncol. 31B:181–187.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Yamano Y, Uzawa K, Shinozuka K, Fushimi K,
Ishigami T, Nomura H, Ogawara K, Shiiba M, Yokoe H and Tanzawa H:
Hyaluronan-mediated motility: a target in oral squamous cell
carcinoma. Int J Oncol. 32:1001–1009. 2008.PubMed/NCBI
|
|
7.
|
Wang Y, Lee GF, Kelley RF and Spellman MW:
Identification of a GDP-L-fucose: polypeptide fucosyltransferase
and enzymatic addition of O-linked fucose to EGF domains.
Glycobiology. 6:837–842. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Koike H, Uzawa K, Grzesik WJ, Seki N, Endo
Y, Kasamatsu A, Yamauchi M and Tanzawa H: GLUT1 is highly expressed
in cementoblasts but not in osteoblasts. Connect Tissue Res.
46:117–124. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Kasamatsu A, Uzawa K, Nakashima D, Koike
H, Shiiba M, Bukawa H, Yokoe H and Tanzawa H: Galectin-9 as a
regulator of cellular adhesion in human oral squamous cell
carcinoma cell lines. Int J Mol Med. 16:269–273. 2005.PubMed/NCBI
|
|
10.
|
Endo Y, Uzawa K, Mochida Y, Shiiba M,
Bukawa H, Yokoe H and Tanzawa H: Sarcoendoplasmic reticulum Ca(2+)
ATPase type 2 downregulated in human oral squamous cell carcinoma.
Int J Cancer. 110:225–231. 2004.
|
|
11.
|
Sakuma K, Kasamatsu A, Yamatoji M, Yamano
Y, Fushimi K, Iyoda M, Ogoshi K, Shinozuka K, Ogawara K, Shiiba M,
Tanzawa H and Uzawa K: Expression status of Zic family member 2 as
a prognostic marker for oral squamous cell carcinoma. J Cancer Res
Clin Oncol. 136:553–559. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Yamatoji M, Kasamatsu A, Kouzu Y, Koike H,
Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K:
Dermatopontin: a potential predictor for metastasis of human oral
cancer. Int J Cancer. 130:2903–2911. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Yamatoji M, Kasamatsu A, Yamano Y, Sakuma
K, Ogoshi K, Iyoda M, Shinozuka K, Ogawara K, Takiguchi Y, Shiiba
M, Tanzawa H and Uzawa K: State of homeobox A10 expression as a
putative prognostic marker for oral squamous cell carcinoma. Oncol
Rep. 23:61–67. 2010.PubMed/NCBI
|
|
14.
|
Kato Y, Uzawa K, Yamamoto N, Kouzu Y,
Koike H, Shiiba M, Bukawa H, Yokoe H, Shibahara T and Tanzawa H:
Overexpression of Septin1: possible contribution to the development
of oral cancer. Int J Oncol. 31:1021–1028. 2007.PubMed/NCBI
|
|
15.
|
Kouzu Y, Uzawa K, Koike H, Saito K,
Nakashima D, Higo M, Endo Y, Kasamatsu A, Shiiba M, Bukawa H, Yokoe
H and Tanzawa H: Overexpression of stathmin in oral squamous-cell
carcinoma: correlation with tumour progression and poor prognosis.
Br J Cancer. 94:717–723. 2006.PubMed/NCBI
|
|
16.
|
Iyoda M, Kasamatsu A, Ishigami T,
Nakashima D, Endo-Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and
Uzawa K: Epithelial cell transforming sequence 2 in human oral
cancer. PLoS One. 5:e140822010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Onda T, Uzawa K, Nakashima D, Saito K,
Iwadate Y, Seki N, Shibahara T and Tanzawa H: Lin-7C/VELI3/MALS-3:
an essential component in metastasis of human squamous cell
carcinoma. Cancer Res. 67:9643–9648. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Saito Y, Kasamatsu A, Yamamoto A, Shimizu
T, Yokoe H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K:
ALY as a potential contributor to metastasis in human oral squamous
cell carcinoma. J Cancer Res Clin Oncol. 139:585–594. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Koike K, Kasamatsu A, Iyoda M, Saito Y,
Kouzu Y, Koike H, Sakamoto Y, Ogawara K, Tanzawa H and Uzawa K:
High prevalence of epigenetic inactivation of the human four and a
half LIM domains 1 gene in human oral cancer. Int J Oncol.
42:141–150. 2013.PubMed/NCBI
|
|
20.
|
Usukura K, Kasamatsu A, Okamoto A, Kouzu
Y, Higo M, Koike H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and
Uzawa K: Tripeptidyl peptidase II in human oral squamous cell
carcinoma. J Cancer Res Clin Oncol. 139:123–130. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Verburg FA, Wäschle K, Reiners C,
Giovanella L and Lentjes EG: Heterophile antibodies rarely
influence the measurement of thyroglobulin and thyroglobulin
antibodies in differentiated thyroid cancer patients. Horm Metab
Res. 42:736–739. 2010. View Article : Google Scholar
|
|
22.
|
Imam JS, Buddavarapu K, Lee-Chang JS,
Ganapathy S, Camosy C, Chen Y and Rao MK: MicroRNA-185 suppresses
tumor growth and progression by targeting the Six1 oncogene in
human cancers. Oncogene. 29:4971–4979. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Ogoshi K, Kasamatsu A, Iyoda M, Sakuma K,
Yamatoji M, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K:
Dickkopf-1 in human oral cancer. Int J Oncol. 39:329–336.
2011.PubMed/NCBI
|
|
24.
|
Schuster-Gossler K, Harris B, Johnson KR,
Serth J and Gossler A: Notch signalling in the paraxial mesoderm is
most sensitive to reduced POFUT1 levels during early mouse
development. BMC Dev Biol. 9:62009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Stanley P and Guidos CJ: Regulation of
Notch signaling during T- and B-cell development by O-fucose
glycans. Immunol Rev. 230:201–215. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Gurvich N, Perna F, Farina A, Voza F,
Menendez S, Hurwitz J and Nimer SD: L3MBTL1 polycomb protein, a
candidate tumor suppressor in del(20q12) myeloid disorders, is
essential for genome stability. Proc Natl Acad Sci USA.
107:22552–22557. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Mackinnon RN, Selan C, Wall M, Baker E,
Nandurkar H and Campbell LJ: The paradox of 20q11.21 amplification
in a subset of cases of myeloid malignancy with chromosome 20
deletion. Genes Chromosomes Cancer. 49:998–1013. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Kroes RA, Dawson G and Moskal JR: Focused
microarray analysis of glycogene expression in human glioblastomas.
J Neurochem. 103(Suppl 1): 14–24. 2007. View Article : Google Scholar
|
|
29.
|
Loo LW, Tiirikainen M, Cheng I, Lum-Jones
A, Seifried A, Church JM, Gryfe R, Weisenberger DJ, Lindor NM,
Gallinger S, Haile RW, Duggan DJ, Thibodeau SN, Casey G and Le
Marchand L: Integrated analysis of genome-wide copy number
alterations and gene expression in microsatellite stable, CpG
island methylator phenotype-negative colon cancer. Genes
Chromosomes Cancer. 52:450–466. 2013. View Article : Google Scholar : PubMed/NCBI
|
